David Gailani

12.4k citations

219 papers · 9.3k indexed · 4 hit papers · h-index 51

Impact in

Genetics top 0.05%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Hematology top 0.05%
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments

Papers in

Genetics 187
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 186
Hematology 163
- Blood Coagulation and Thrombosis Mechanisms 145
- Hemophilia Treatment and Research 43
- Platelet Disorders and Treatments 25

Co-authors: Thomas Renné George Broze András Gruber Mao-fu Sun Erik I. Tucker Owen J. T. McCarty Anton Matafonov Bernhard Nieswandt
Journals: Blood (53 papers)Journal of Thrombosis and Haemostasis (29 papers)Journal of Biological Chemistry (15 papers)Arteriosclerosis Thrombosis and Vascular Biology (10 papers)Research and Practice in Thrombosis and Haemostasis (9 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

David Gailani

210 papers receiving 9.2k citations

Hit Papers

align trajectories log scale

Milvexian for the Prevention of Venous Thromboembolism 2021 · 162 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 New England Journal of Medicine
2014 New England Journal of Medicine
2005 The Journal of Experimental Medicine
1991 Science

Peers

Countries citing papers authored by David Gailani

Since Specialization

Citations

This map shows the geographic impact of David Gailani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gailani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gailani more than expected).

Fields of papers citing papers by David Gailani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gailani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gailani. The network helps show where David Gailani may publish in the future.

Co-authors

The 25 scholars most cited alongside David Gailani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Gailani Line = papers co-authored together David Gailani links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Investigation of the Influence of Lipoprotein(a) and Oxidized Lipoprotein(a) on Plasminogen Activation and Fibrinolysis Journal of Lipid and Atherosclerosis ·J. H. Frank, S. Kent Dickeson, Sébastien Czernichow, Sergey O. Solomevich, Eli S. Lachance, David Gailani, Wen‐Liang Song	2025	0
2	Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo Blood ·Cristina Puy, Nico A Blom, Jiaqing Pang, PhilipR. Wyatt, 延行池田, Christina U. Lorentz, Erik I. Tucker, Joseph J. Shatzel, Ravi S. Keshari, Florea Lupu, David Gailani, Owen J. T. McCarty	2024	11
3	High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation Journal of Thrombosis and Haemostasis ·Bassem M. Mohammed, Mao-fu Sun, Qiufang Cheng, Mauro Migliazzi, Keith R. McCrae, Jonas Emsley, Owen J. T. McCarty, David Gailani	2023	6
4	Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice Metabolic Brain Disease ·G Rice, C. A. Ward, Maximiliano Puccio, Laura D. Healy, Erik I. Tucker, David Gailani, Owen J. T. McCarty, Arthur A. Vandenbark, Halina Offner, Norah G. Verbout	2023	6
5	First Validated Model of Zymogen Factor XII Provides Insights into Protein Assembly and Activation Blood ·Aleksandr Shamanaev, Mao-fu Sun, Michał B. Ponczek, Jonas Emsley, David Gailani	2023	0
6	PB0592 Evaluation of the Role of Skeletal Muscle Myosin as a Cofactor for Factor XI Activation of Factor XII Research and Practice in Thrombosis and Haemostasis ·Yang Cao, John H. Griffin, David Gailani, Erik I. Tucker, Christina U. Lorentz, Owen J. T. McCarty, Cristina Puy	2023	1
7	Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation Journal of Thrombosis and Haemostasis ·Geoffrey D. Barnes, Walter Ageno, Lana A. Castellucci, Thita Chiasakul, N. Silpa, José Luis Ferreiro, David Gailani, Diana A. Gorog, Gregory Y.H. Lip, Leslie Raffini, Suely Meireles Rezende, Jeffrey I. Weitz, Adam Cuker	2023	8
8	A mechanism for hereditary angioedema caused by a lysine 311–to–glutamic acid substitution in plasminogen Blood ·S. Kent Dickeson, Alwine A. F. Kardinaal, Mao-fu Sun, Bassem M. Mohammed, Dennis Phillips, James C. Whisstock, Adam J. Quek, Edward P. Feener, Ruby H. P. Law, David Gailani	2022	21
9	Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis Journal of Thrombosis and Haemostasis ·Kelley R. Jordan, Cory Wyatt, C. A. Ward, Randy Woltjer, Edward A. Neuwelt, O. Ã–zsarlak, David Gailani, Christina U. Lorentz, Erik I. Tucker, Owen J. T. McCarty, Monica T. Hinds, Khanh P. Nguyen	2022	14
10	Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI Proceedings of the National Academy of Sciences ·Katherine J. Kearney, 誠野村, Ellen Romance, Clare Wilson, Haifa Rashed, Majid Ali, Ahmed Khalil, Josefin Ahnström, David Gailani, Richard Foster, Emma Hethershaw, Colin Longstaff, Helen Philippou	2021	46
11	The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial Blood ·Christina U. Lorentz, Erik I. Tucker, Norah G. Verbout, Joseph J. Shatzel, Sven R. Olson, Brandon D. Markway, Michael Wallisch, Martina Ralle, Monica T. Hinds, Owen J. T. McCarty, David Gailani, Jeffrey I. Weitz, András Gruber	2021	89
12	Factor XII plays a pathogenic role in organ failure and death in baboons challenged withStaphylococcus aureus Blood ·Robert Silasi‐Mansat, Ravi S. Keshari, 吉崎麻子, Cristina Lupu, Constantin Georgescu, Joe H. Simmons, Michael Wallisch, G Rice, Joseph J. Shatzel, Sven R. Olson, Christina U. Lorentz, Cristina Puy, Erik I. Tucker, David Gailani, Sidney Strickland, András Gruber, Owen J. T. McCarty, Florea Lupu	2021	19
13	Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis Cellular and Molecular Bioengineering ·G Rice, Christina U. Lorentz, Jennifer Johnson, Cristina Puy, Sven R. Olson, Joseph J. Shatzel, David Gailani, Monica T. Hinds, Erik I. Tucker, András Gruber, Owen J. T. McCarty, Michael Wallisch	2020	15
14	Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates Research and Practice in Thrombosis and Haemostasis ·Michael Wallisch, Christina U. Lorentz, 张冰歌, Jennifer Johnson, Luz Eugenia Idárraga Montoya, Cristina Puy, David Gailani, Monica T. Hinds, Owen J. T. McCarty, András Gruber, Erik I. Tucker	2020	41
15	Phenotype of ribonuclease 1 deficiency in mice RNA ·Jacqueline Boniffay, Jo E. Lomax, Bassem M. Mohammed, David Gailani, 黄九林, Ronald T. Raines	2019	16
16	Protease activity in single-chain prekallikrein Blood ·Ivan Ivanov, Ingrid M. Verhamme, Mao-fu Sun, Bassem M. Mohammed, Qiufang Cheng, Anton Matafonov, S. Kent Dickeson, Kusumam Joseph, Allen P. Kaplan, David Gailani	2019	29
17	Inhibition of contact-mediated activation of factor XI protects baboons against S aureus–induced organ damage and death Blood Advances ·Robert Silasi‐Mansat, Ravi S. Keshari, Cristina Lupu, Walter J. Janse van Rensburg, Hala Chaaban, 吉崎麻子, Aleksandr Shamanaev, Joseph J. Shatzel, Cristina Puy, Christina U. Lorentz, Erik I. Tucker, David Gailani, András Gruber, Owen J. T. McCarty, Florea Lupu	2019	57
18	Dilutional coagulopathy in pediatric scoliosis surgery: A single center report Pediatric Anesthesia ·Courtney E. Baker, Nurul Shazwani Abdul Aziz, Thomas M. Austin, Shelby Payne, Megan E. Mignemi, David Gailani, Allison P. Wheeler, Thanh Tan Nguyen, Steven A. Lovejoy, Jeffrey E. Martus, Gregory A. Mencio, Jonathan G. Schoenecker	2018	6
19	Murine Models in the Evaluation of Heparan Sulfate-Based Anticoagulants Methods in molecular biology ·David Gailani, Qiufang Cheng, Ivan Ivanov	2014	8
20	Sucrose Octasulfate Selectively Accelerates Thrombin Inactivation by Heparin Cofactor II Journal of Biological Chemistry ·Laye Andrew, Sônia Carine Cova, Dmitri V. Kravtsov, Anton Matafonov, David Gailani, Ingrid M. Verhamme	2010	6

About David Gailani

David Gailani is a scholar working on Genetics, Hematology, Nutrition and Dietetics, Internal Medicine and Immunology, having authored 219 papers that have together received 9.3k indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (186 papers), Blood Coagulation and Thrombosis Mechanisms (145 papers), Vitamin K Research Studies (56 papers), Hemophilia Treatment and Research (43 papers), Mast cells and histamine (30 papers), Platelet Disorders and Treatments (25 papers), Protease and Inhibitor Mechanisms (15 papers) and Venous Thromboembolism Diagnosis and Management (10 papers). The work is most often cited by research in Genetics (6.1k citations), Hematology (6.0k citations), Internal Medicine (865 citations), Nutrition and Dietetics (1.9k citations) and Immunology (1.5k citations). David Gailani has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Thomas Renné, George Broze, András Gruber, Mao-fu Sun, Erik I. Tucker, Owen J. T. McCarty, Anton Matafonov, Bernhard Nieswandt, Qiufang Cheng and Kai Schuh. Their work appears in journals such as Blood, Journal of Thrombosis and Haemostasis, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Research and Practice in Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact